Results 41 to 50 of about 21,287 (236)

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression [PDF]

open access: yesKidney Research and Clinical Practice, 2022
Background Autosomal dominant polycystic kidney disease (ADPKD), one of the most common human monogenic diseases, is characterized by the presence of numerous fluid-filled renal cysts and is a leading cause of end-stage renal disease (ESRD).
Hyunsuk Kim   +5 more
doaj   +1 more source

Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States

open access: yesAmerican Society of Nephrology. Clinical Journal, 2022
Visual Abstract Background and objectives Autosomal dominant polycystic kidney disease (ADPKD) occurs at conception and is often diagnosed decades prior to kidney failure.
R. McGill   +3 more
semanticscholar   +1 more source

ARPKD and ADPKD [PDF]

open access: yesJournal of the American Society of Nephrology, 2008
Superficially, autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) seem to be more different than alike. ADPKD is common, its cysts arise from any nephron segment, and it is slowly progressive.[1][1] Hepatic cysts are its primary ...
Jun-ya Kaimori, Gregory G. Germino
openaire   +2 more sources

aksg87/adpkd-segmentation-pytorch: ADPKD Segmentation models v1.0

open access: yes, 2021
ADPKD Segmentation models v1.0 Training pipeline implementation. Inference script with best model and checkpoint. Extensive experiment documentation via Tensorboard runs and YAML config files. Total kidney volume metric calculation.
Akshay Goel
core   +1 more source

Giant Bilateral Adrenal Myelolipoma: Case Report

open access: yesIndian Journal of Endocrinology and Metabolism, 2020
Adrenal myelolipomas are nonfunctional tumors that are usually asymptomatic; however, they have been known to coexist with other endocrine disorders, such as Cushing's syndrome, congenital adrenal hyperplasia (CAH), Conn's syndrome, and pheochromocytoma.
B Rathna Roger   +3 more
doaj   +1 more source

Patients with Protein-Truncating PKD1 Mutations and Mild ADPKD.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2021
BACKGROUND AND OBJECTIVES Progression of autosomal dominant polycystic kidney disease (ADPKD) is highly variable. On average, protein-truncating PKD1 mutations are associated with the most severe kidney disease among all mutation classes. Here, we report
M. Lanktree   +11 more
semanticscholar   +1 more source

Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease. [PDF]

open access: yesPLoS ONE, 2014
Polycystin 1 and 2, the protein abnormalities associated with autosomal dominant polycystic kidney disease (ADPKD), are also found in airway cilia and smooth muscle cells.
Teng Moua   +6 more
doaj   +1 more source

Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2021
BACKGROUND AND OBJECTIVES Predicting disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD) poses a challenge, especially in early-stage disease when kidney function is not yet affected.
Judith E. Heida   +6 more
semanticscholar   +1 more source

Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study [PDF]

open access: yes, 2013
Treatment options for autosomal dominant polycystic kidney disease (ADPKD) will likely become available in the near future, hence reliable diagnostic and prognostic biomarkers for the disease are strongly needed.
Torres, Vicente E.   +114 more
core   +2 more sources

RECURRENT HAPLOTYPE IN ADPKD PATIENTS WITH THE SAME GERMLINE NONSENSE MUTATION IN THE PKD2 GENE [PDF]

open access: yes, 2022
openLa malattia autosomica dominante del Rene Policistico (Autosomal Dominant Polycystic Kidney Disease, ADPKD) è la più comune malattia genetica renale nella popolazione mondiale e in Europa è la quarta causa di CKD (Chronic Kidney Disease) che ...
RADONIC, SARA
core  

Home - About - Disclaimer - Privacy